Dow Mark A. 4
4 · KV PHARMACEUTICAL CO /DE/ · Filed May 16, 2012
Insider Transaction Report
Form 4
Dow Mark A.
Director
Transactions
- Award
Option to Purchase
2012-05-14+20,000→ 20,000 totalExercise: $0.94Exp: 2022-05-14→ Class A Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option vests 33% on May 14, 2013, 33% on May 14, 2014 and 34% on May 14, 2015.